cbdMD (YCBD) Gross Margin Growth (3y) (2020 - 2026)
cbdMD (YCBD) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | -481.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -481.00 |
| Dec 31, 2025 | 265.00 |
| Sep 30, 2025 | 695.00 |
| Jun 30, 2025 | -759.00 |
| Mar 31, 2025 | -460.00 |
| Dec 31, 2024 | 1,584.00 |
| Sep 30, 2024 | -616.00 |
| Jun 30, 2024 | 245.00 |
| Mar 31, 2024 | -650.00 |
| Dec 31, 2023 | -158.00 |
| Sep 30, 2023 | 2,390.00 |
| Jun 30, 2023 | -89.00 |
| Mar 31, 2023 | -658.00 |
| Sep 30, 2022 | 5,200.00 |
| Jun 30, 2022 | 1,690.00 |
| Mar 31, 2022 | 6,927.00 |
| Dec 31, 2021 | 676.00 |
| Sep 30, 2021 | 5,932.00 |
| Jun 30, 2021 | -4,967.00 |
| Mar 31, 2021 | -1,739.00 |